Keyword Connections

lenalidomide

Journals

9

1 PloS one

2 PLoS computational biology

3 journal of nursing care quality

4 The Journal of nervous and mental disease

5 hematological oncology

6 Clinical and experimental rheumatology

7 Transplantation proceedings

8 Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

9 international journal of hematology

Research Groups

0

No Research Group Connected

Bibliographies

18

1 A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone.

2 Knowledge and Attitudes of Students of the Rzeszow University About the Transplantation of Organs.

3 Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma.

4 The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5

5 Cytomegalovirus Retinitis Associated with Lenalidomide Use for Multiple Myeloma in an Immunocompetent Patient

6 The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm.

7 Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial

8 (Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials

9 lenalidomide-induced pure red cell aplasia

10 brain abscesses caused by nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.

11 Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

12 Continuous lenalidomide treatment for newly diagnosed multiple myeloma

13 Lenalidomide: a review of its continuous use in patients with newly diagnosed multiple myeloma not eligible for stem-cell transplantation

14 Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

15 Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

16 Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

17 Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial

18 Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience